12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

PDI Inc. sales and marketing update

PDI's Interpace BioPharma LLC business unit will market an undisclosed drug to treat knee pain in the U.S. under...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >